119 related articles for article (PubMed ID: 26068922)
1. Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
Milani M; Laranjeira AB; de Vasconcellos JF; Brandalise SR; Nowill AE; Yunes JA
PLoS One; 2015; 10(6):e0129298. PubMed ID: 26068922
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
[TBL] [Abstract][Full Text] [Related]
4. HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias.
Mshaik R; Simonet J; Georgievski A; Jamal L; Bechoua S; Ballerini P; Bellaye PS; Mlamla Z; Pais de Barros JP; Geissler A; Francin PJ; Girodon F; Garrido C; Quéré R
Blood Cancer J; 2021 Mar; 11(3):61. PubMed ID: 33737511
[TBL] [Abstract][Full Text] [Related]
5. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
6. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
7. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.
Arguello F; Sterry JA; Zhao YZ; Alexander MR; Shoemaker RH; Cohen HJ
Blood; 1996 May; 87(10):4325-32. PubMed ID: 8639792
[TBL] [Abstract][Full Text] [Related]
8. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
10. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
[TBL] [Abstract][Full Text] [Related]
11. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
12. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
[TBL] [Abstract][Full Text] [Related]
13. SLAM family predicting the initiation potential of human acute lymphoblastic leukemia in NOD/SCID mice.
Wang N; Xiao F; Liu JP; Wang D; Geng Z; Wang J; Ma SY; Shu LL; Chen TP; Zhou JF; Huang L
Chin Med J (Engl); 2011 Oct; 124(19):3074-9. PubMed ID: 22040559
[TBL] [Abstract][Full Text] [Related]
14. Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody.
Pesnel S; Pillon A; Créancier L; Lerondel S; Le Pape A; Recher C; Demur C; Guilbaud N; Kruczynski A
PLoS One; 2012; 7(1):e30690. PubMed ID: 22303450
[TBL] [Abstract][Full Text] [Related]
15. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
Ramírez M; Díaz MA; Madero L; Bueren JA
Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
[TBL] [Abstract][Full Text] [Related]
17. Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2012 Dec; 41(6):2207-12. PubMed ID: 23041950
[TBL] [Abstract][Full Text] [Related]
18. Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Gyurkocza B; Plescia J; Raskett CM; Garlick DS; Lowry PA; Carter BZ; Andreeff M; Meli M; Colombo G; Altieri DC
J Natl Cancer Inst; 2006 Aug; 98(15):1068-77. PubMed ID: 16882944
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
20. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
